Latest Breaking News On - Regeneron pharmaceuticals inc - Page 12 : comparemela.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN)..

City ofUnited kingdomFrance generalUnited statesNew yorkTel avivLos angelesDanielle peytonAbrahaml pomerantzRegeneron eyleaPrnewswire pomerantzRegeneron pharmaceuticals incUs department of justiceRegeneron pharmaceuticalsFalse claims

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.

San diegoUnited statesLungenclinic grosshansdorfSurya bhattKlaus rabeUniversity of alabama at birminghamRegeneron pharmaceuticals incAmerican thoracic society international conferenceNew england journalUnited states foodDrug administrationBirmingham departmentMedicine divisionCritical careRegeneron pharmaceuticalsThoracic society international conference

Lexington 16-year-old student wins $75,000 for what could be a medical breakthrough

(TNS) A 16-year-old junior from Lexington’s Paul Laurence Dunbar High School on Friday won $75,000 and worldwide recognition for her improvement on an implantable medical device that could work inside

Los angelesGeorged yancopoulosRegeneron pharmaceuticals incSociety for scienceRegeneron international scienceLexington paul laurence dunbar high school onPaul laurence dunbar high schoolInternational scienceEngineering fairRegeneron pharmaceuticalsScience news exploresInnovator award

Regeneron Pharmaceuticals On Pace for Record High Close — Data Talk

Regeneron Pharmaceuticals On Pace for Record High Close — Data Talk
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Dow jones company incRegeneron pharmaceuticals incRegeneron pharmaceuticalsDow jones market dataDow jones

Balentine LLC Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Balentine LLC lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,399 shares of the biopharmaceutical company’s stock after purchasing an additional 97 shares during the period. Balentine LLC’s […]

Sanfordc bernsteinMarion mccourtJosephj larosaCriterion capital advisorsFortitude family officeRegeneron pharmaceuticals price performanceRegeneron pharmaceuticalsExchange commissionQuarter for regeneron pharmaceuticalsRoyal bankAnnis gardner whiting capital advisorsRegeneron pharmaceuticals incRegeneron pharmaceuticals company profileSutton wealth advisors incNews ratings for regeneron pharmaceuticals dailyFree report